This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Afinitor
  • /
  • A Study of E7080 Alone, and in Combination With Ev...
Clinical trial

A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment

Read time: 1 mins
Last updated:1st Aug 2010
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest